Position in ABBV
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$19,699,889
+$136,012 QoQ
Shares Held
78,286
-13.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#613
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. ABBV ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,699,889 | 78,286 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $19,563,877 | 89,953 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $19,623,406 | 85,883 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $19,773,979 | 85,402 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $12,121,914 | 65,305 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $14,552,840 | 69,458 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $12,486,801 | 70,269 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $13,897,457 | 70,374 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $10,144,893 | 59,147 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $10,681,986 | 58,660 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $8,296,318 | 53,535 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $7,978,436 | 53,525 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $5,587,657 | 41,473 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $7,016,423 | 44,026 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $6,311,032 | 39,051 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $8,034,481 | 59,865 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,896,733 | 12,384 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,995,411 | 12,309 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,819,776 | 13,440 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,404,251 | 13,018 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,492,142 | 13,247 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,381,752 | 12,768 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,356,626 | 12,661 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,040,131 | 11,875 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,143,502 | 11,647 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $675,271 | 8,863 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||